Search Results
Jan 07, 2026, 08:00 ET SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration that
More news about: SOPHiA GENETICS
Dec 12, 2025, 10:15 ET AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
Inc. (NASDAQ: AMZN) company, Absci Corporation (NASDAQ: ABSI), Certara, Inc. (NASDAQ: CERT), and SOPHiA GENETICS SA (NASDAQ: SOPH as leaders capturing the transformation. Alongside these developments in the broader industry, Aleen Inc. (CSE: ALEN-U) is advancing within the
More news about: Equity Insider
Nov 11, 2025, 09:00 ET SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics'
More news about: SOPHiA GENETICS
Nov 11, 2025, 09:00 ET Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025
sequencing, today announced a collaboration with SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics'
More news about: Complete Genomics
Nov 11, 2025, 08:01 ET SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific
More news about: SOPHiA GENETICS
Nov 11, 2025, 08:01 ET SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific
More news about: SOPHiA GENETICS
Nov 04, 2025, 06:45 ET SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
BOSTON and ROLLE, Switzerland, Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended September 30, 2025.
More news about: SOPHiA GENETICS
Oct 21, 2025, 08:00 ET SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
BOSTON and ROLLE, Switzerland, Oct. 21, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2025 before U.S. markets
More news about: SOPHiA GENETICS
Oct 17, 2025, 11:39 ET A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben
SOPHiA GENETICS (Nasdaq: SOPH), ein KI-Technologieunternehmen, das Pionierarbeit in der datengesteuerten Medizin leistet, gaben heute auf dem ESMO eine strategische Vereinbarung bekannt,
More news about: SOPHiA GENETICS
Oct 17, 2025, 09:49 ET A.D.A.M. Innovations et SOPHiA GENETICS s'associent pour faire progresser les tests de biopsie liquide et les diagnostics compagnons pour l'oncologie de précision au Japon
SOPHiA GENETICS (Nasdaq : SOPH), une société de technologie de l'IA pionnière de la médecine basée sur les données, ont annoncé aujourd'hui à l'ESMO un accord stratégique visant à
More news about: SOPHiA GENETICS
Oct 17, 2025, 09:37 ET A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan
SOPHiA GENETICS (Nasdaq: SOPH), een AI-technologiebedrijf dat baanbrekend werk verricht op het gebied van datagestuurde geneeskunde, kondigde vandaag op de ESMO een strategische overeenkomst
More news about: SOPHiA GENETICS
Oct 16, 2025, 11:00 ET A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic
More news about: SOPHiA GENETICS
Oct 16, 2025, 11:00 ET A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic
More news about: SOPHiA GENETICS
Oct 16, 2025, 04:01 ET SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates
More news about: SOPHiA GENETICS
Oct 16, 2025, 04:01 ET SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates
More news about: SOPHiA GENETICS
Sep 23, 2025, 08:01 ET Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with
More news about: SOPHiA GENETICS
Sep 23, 2025, 08:01 ET Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with
More news about: SOPHiA GENETICS
Sep 22, 2025, 08:00 ET SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN)
More news about: SOPHiA GENETICS
Sep 22, 2025, 08:00 ET SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN)
More news about: SOPHiA GENETICS